Skip to main content
OpenTrials

Clinical trial condition

Liver Diseases

Explore clinical trials studying Liver Diseases. Study availability and eligibility vary by location and protocol.

8,421 public trials 1,317 recruiting studies
Refine in advanced search Browse all conditions

Liver Diseases trial results

Completed

A Phase I / II Trial of Nintedanib in Asian Hepatocellular Carcinoma Patients

NCT00987935

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
Locations
  • 1199.39.82001 Boehringer Ingelheim Investigational Site Seoul, South Korea
  • 1199.39.82002 Boehringer Ingelheim Investigational Site Seoul, South Korea
  • 1199.39.82003 Boehringer Ingelheim Investigational Site Seoul, South Korea
  • 1199.39.82004 Boehringer Ingelheim Investigational Site Seoul, South Korea
View all 16 locations
View Trial Details
Completed

A Follow-Up Study to WV19432, to Evaluate Long Term Post-Treatment Effects of PEGASYS (Peginterferon Alfa-2a(40KD))in Patients With HBeAg Positive Chronic Hepatitis B

NCT00927082

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Fitzroy, Victoria, Australia
  • Salvador, Estado de Bahia, Brazil
  • Campinas, São Paulo, Brazil
  • Ribeirão Preto, São Paulo, Brazil
View all 31 locations
View Trial Details
Completed

A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Enrolled in a Methadone Maintenance Treatment Program.

NCT00087594

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • San Francisco, California, United States
  • Farmington, Connecticut, United States
  • Honolulu, Hawaii, United States
  • Downers Grove, Illinois, United States
View Trial Details

Related conditions